Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find

Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.

Patients treated with a combination of the anti-inflammatory drug baricitinib and the antiviral drug remdesivir while they were receiving high-flow oxygen or noninvasive ventilation had a recovery time of 10 days, compared with 18 days for patients in a remdesivir-only control group.

Read more about Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find.